Black Diamond Therapeutics, Inc.
BDTX
$1.63
$0.031.88%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.75% | 21.86% | -9.24% | 6.10% | 15.64% |
| Total Depreciation and Amortization | -1.16% | 0.00% | 0.00% | 0.00% | -25.22% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -0.66% | -65.74% | 223.39% | 4.72% | -56.19% |
| Change in Net Operating Assets | -132.96% | 1,041.01% | 104.75% | -216.41% | 216.28% |
| Cash from Operations | -32.96% | 23.11% | 30.53% | -51.90% | 24.00% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -83.33% | 26.32% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1,194.22% | 205.56% | 105.11% | -212.12% | 132.36% |
| Cash from Investing | 1,166.26% | 196.35% | 105.39% | -212.12% | 132.33% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 417.63% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 215.48% | -101.18% | 417.63% | 9,078.26% | -100.06% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 238.62% | -226.92% | 124.00% | -1,657.16% | -111.18% |